Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Increasing CSL concentration to 5% and 10% (v/v) significantly increased glutathione production concentration, resulting in 2.1- and 2.4-fold improvements, respectively, compared to the YCK50D medium (Fig
Est en toda la pgina web"
(Original) Excellent services
Feb 15: EMD Serono, a Merck KGaA company, got a win Thursday as the FDA converted Tepmetkos February 2021 accelerated nod to full approval for adult non-small cell lung cancer (NSCLC) patients whose disease harbors mesenchymal-epithelial transition (MET) exon 14 skipping alterations
US$ 23.53
US$ 27.25
US$ 21.76
